Brightworth’s CME Group CME Stock Holding History

Brightworth’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,307	Closed	-$299K	–	122
2021 Q4	$299K	Buy	1,307 +28	+2%	+$6.16K	0.03%	106
2021 Q3	$247K	Buy	+1,279	New	+$259K	0.02%	103

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brightworth's CME Position: Q1 2022 in Review

Brightworth sold out of CME Group (CME) in Q1 2022, closing a stake of 1,307 shares — an estimated $299K sold.

Brightworth first reported a position in CME in Q3 2021 and held it in 2 quarters. The position peaked at $299K in Q4 2021. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

Brightworth reported no remaining CME Group position as of Q1 2022 after selling out during the quarter.
Brightworth sold 1,307 CME Group shares in Q1 2022, an estimated $299K.
Brightworth first reported a position in CME Group in Q3 2021 and held it in 2 quarters.
Brightworth's CME Group position peaked at $299K in Q4 2021.
1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Brightworth's 13F filing for Q1 2022, filed 29 Apr 2022.